Published in

Elsevier, Journal of Lipid Research, 12(54), p. 3334-3344, 2013

DOI: 10.1194/jlr.m040519

Links

Tools

Export citation

Search in Google Scholar

A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Increased levels of bile acids due to the various hepatic diseases could interfere with the metabolism of xenobiotics such as drugs, and endobiotics including steroid hormones. UDP-glucuronosyltransferases (UGTs) are involved in the conjugation and elimination of many xenobiotics and endogenous compounds. The present study sought to investigate the potential for inhibition of UGT enzymes by bile acids. The results showed that taurolithocholic acid (TLCA) exhibited the strongest inhibition towards UGTs, followed by lithocholic acid (LCA). Bile acids structure-UGT inhibition relationships were examined and in vitro-in vivo extrapolation performed by using in vitro inhibition kinetic parameters (Ki) in combination with calculated in vivo levels of taurolithocholic acid (TLCA). Substitution of a hydrogen with a hydroxyl group in the R1, R3, R4, R5 site of bile acids significantly weakens their inhibition ability towards most UGTs. The in vivo inhibition by taurolithocholate (TLCA) towards UGT forms was determined with following orders of potency: UGT1A4 > UGT2B7 > UGT1A3 > UGT1A1 ~ UGT1A7 ~ UGT1A10 ~ UGT2B15. In conclusion, these studies suggest that disrupted homeostasis of bile acids, notably taurolithocholic acid, found in various diseases such as cholestasis, could lead to altered metabolism of xenobiotics and endobiotics through inhibition of UGT enzymes.